TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32580211

Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: External beam radiotherapy
Number of subjects: 0
Study: 36348363

Group type: EXPERIMENTAL
Intervention: Carbon ion radiotherapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Simultaneous integrated boost carbon ion radiotherapy
Number of subjects: 140
Study: 34477473

Group type: EXPERIMENTAL
Intervention: Prolonged-release Hydeal-D 0.2% vaginal gel applied every three days for 12 weeks
Number of subjects: 85

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Prolonged-release Hydeal-D 0.2% vaginal gel
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 85
Study: 32729363

Group type: EXPERIMENTAL
Intervention: Antiviral drugs (specific drugs not mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-drug combination therapy
Number of subjects: 0
Study: 35798248

Group type: EXPERIMENTAL
Intervention: WW + AVOID
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: WW + RESIST
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: WW + AVOID + RESIST
Number of subjects: 500

Group type: COMPARATOR
Intervention: WW alone
Number of subjects: 500
Study: 34637408

Group type: EXPERIMENTAL
Intervention: Microdiscectomy
Number of subjects: 128

Group type: COMPARATOR
Intervention: Standardized nonoperative care
Number of subjects: 128
Study: 34977961

Group type: EXPERIMENTAL
Intervention: Repeated sprint training under hypoxia (RSH, FIO2=14.5%)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Repeated sprint training under normoxia (RSN, FIO2=20.9%)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: RSH
Number of subjects: 14
Study: 32802264

Group type: EXPERIMENTAL
Intervention: NSDP plus supragingival irrigation with aerosolized 0.5% hydrogen peroxide (H2O2) solution
Number of subjects: 35

Group type: COMPARATOR
Intervention: NSDP alone
Number of subjects: 35
Study: 35549696

Group type: EXPERIMENTAL
Intervention: Volar locking plate (VLP) fixation
Number of subjects: 140

Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 140
Study: 34583237

Group type: EXPERIMENTAL
Intervention: Weak wiping pressure (12-14 mmHg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Ordinary wiping pressure (23-25 mmHg)
Number of subjects: 47
Study: 35436135

Group type: EXPERIMENTAL
Intervention: Impella device
Number of subjects: 0
Study: 35606663

Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg
Number of subjects: 1386

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1386

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 1386
Study: 32484236

Group type: EXPERIMENTAL
Intervention: HPV16/18 positive women with negative cytology
Number of subjects: 2300

Group type: EXPERIMENTAL
Intervention: HPV16/18 positive women with HSIL+ cytology
Number of subjects: 2300

Group type: EXPERIMENTAL
Intervention: HPV16/18 positive women
Number of subjects: 2300

Group type: EXPERIMENTAL
Intervention: Women with ASC-H cytology
Number of subjects: 2300

Group type: EXPERIMENTAL
Intervention: Women younger than 35 years
Number of subjects: 2300

Group type: EXPERIMENTAL
Intervention: Women aged 65 to 74 years
Number of subjects: 2300
Study: 36058838

Group type: EXPERIMENTAL
Intervention: Food addiction
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Disease
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Caloric imbalance
Number of subjects: 249

Group type: COMPARATOR
Intervention: Control group (unrelated article)
Number of subjects: 249
Study: 33578328

Group type: EXPERIMENTAL
Intervention: V‐DACPR with rapid transition
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: V‐DACPR with delayed transition
Number of subjects: 131

Group type: COMPARATOR
Intervention: C‐DACPR
Number of subjects: 131
Study: 32302347

Group type: EXPERIMENTAL
Intervention: Melatonin 20mg before and during the first cycle of chemotherapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 616379577

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA/min) stimulation to the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 50
Study: 35154575

Group type: EXPERIMENTAL
Intervention: Silymarin (400 mg/day) along with DAAs (Sofosbuvir 400 mg/day and Ribavirin 800 mg/day) for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: DAAs (Sofosbuvir 400 mg/day and Ribavirin 800 mg/day)
Number of subjects: 30
Study: 34634721

Group type: EXPERIMENTAL
Intervention: Mindfetalness
Number of subjects: 18501

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 18501
Study: 32618122

Group type: EXPERIMENTAL
Intervention: Gabapentin at 20 mg/kg per day
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo plus opioid
Number of subjects: 49
Study: 34844816

Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy (ESWT) with 512 impulses of 0.15mJ/mm2, twice per week for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard treatment for burn scars
Number of subjects: 40
Study: 32845997

Group type: EXPERIMENTAL
Intervention: Intravenous N-Acetylcysteine (NAC)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 35925970

Group type: EXPERIMENTAL
Intervention: Standardized maternal meal
Number of subjects: 25

Group type: COMPARATOR
Intervention: Extended fast
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standardized maternal meal vs Extended fast
Number of subjects: 25
Study: 34726542

Group type: EXPERIMENTAL
Intervention: Asynchronous Telepsychiatry (ATP)
Number of subjects: 645

Group type: COMPARATOR
Intervention: Synchronous Telepsychiatry (STP)
Number of subjects: 645
Study: 32302709

Group type: EXPERIMENTAL
Intervention: CDED (Crohn's Disease Exclusion Diet) with 50% enteral nutrition (n = 39)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Exclusive enteral nutrition (EEN) (n = 34)
Number of subjects: 73

Group type: COMPARATOR
Intervention: CDED and EEN
Number of subjects: 73
Study: 35489100

Group type: EXPERIMENTAL
Intervention: Early aerobic exercise (5 days/week, 20 min/day at individualized intensity [80% HR at exercise test cessation])
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard-of-Care (no exercise recommendations)
Number of subjects: 16
Study: 34978552

Group type: EXPERIMENTAL
Intervention: Lyophilized concentrate of purple corn (Zea mays L.) 200 mg
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 36125974

Group type: EXPERIMENTAL
Intervention: Extracorporeal Shockwave Therapy (ESWT) + Stretching Exercises (SEs)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Graston Technique® (GT®) + Stretching Exercises (SEs)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Stretching Exercises (SEs) (Control Group)
Number of subjects: 69
Study: 34112947

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33374687

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTA) injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline solution (SS) injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lidocaine (LD) injection
Number of subjects: 60
Study: 33256462

Group type: EXPERIMENTAL
Intervention: Children from low-income households
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smaller family size, greater food diversity, and good farming practices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Households living under severe levels of poverty
Number of subjects: 0
Study: 33443879

Group type: EXPERIMENTAL
Intervention: Three-dimensional simulation
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Actual outcomes
Number of subjects: 25

Group type: COMPARATOR
Intervention: Preoperative images
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Post-treatment nasofrontal angle
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Post-treatment nasolabial angle
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Actual dosage
Number of subjects: 25
Study: 32503005

Group type: EXPERIMENTAL
Intervention: Behavioral modification program
Number of subjects: 68

Group type: COMPARATOR
Intervention: Minimal intervention (control)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Whole population (≥5% weight loss at 12 months)
Number of subjects: 68
Study: 33838534

Group type: EXPERIMENTAL
Intervention: Low FIO2 group (intraoperative: FIO2 0.35, during induction and recovery: FIO2 0.7)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Conventional FIO2 group (intraoperative: FIO2 0.6, during induction and recovery: FIO2 1.0)
Number of subjects: 190
Study: 33501814

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation environment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Medium-fidelity simulation scenario
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both groups (high-fidelity and medium-fidelity)
Number of subjects: 15
Study: 34371515

Group type: EXPERIMENTAL
Intervention: EC-MPS (nonmedical switching group)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Continuous MMF treatment (control group)
Number of subjects: 54
Study: 33956981

Group type: EXPERIMENTAL
Intervention: MD-informed attention model integrated into BioBERT
Number of subjects: 0

Group type: COMPARATOR
Intervention: BioBERT without MD-informed attention
Number of subjects: 0
Study: 32848381

Group type: EXPERIMENTAL
Intervention: Olodaterol 5 μg
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Olodaterol 10 μg
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Formoterol 12 μg
Number of subjects: 775

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 775
Study: 34230959

Group type: EXPERIMENTAL
Intervention: IS-MiHealth digital tool for screening
Number of subjects: 15780

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 15780
Study: 32234313

Group type: EXPERIMENTAL
Intervention: TTM-based intervention
Number of subjects: 3414

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 3414
Study: 35322857

Group type: EXPERIMENTAL
Intervention: Visual feedback training
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study: 32386811

Group type: EXPERIMENTAL
Intervention: DMEK
Number of subjects: 54

Group type: COMPARATOR
Intervention: UT‐DSAEK
Number of subjects: 54
Study: 33666188

Group type: EXPERIMENTAL
Intervention: Bepotastine 1.5% ophthalmic drops
Number of subjects: 50

Group type: COMPARATOR
Intervention: Olopatadine 0.1% ophthalmic drops
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Laboratory findings of absolute eosinophil count
Number of subjects: 50
Study: 33549312

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy (oral levofloxacin 500 mg and tinidazole 1,000 mg daily for 14 days)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Treatment arm (attempted pregnancy)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control arm (attempted pregnancy)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Treatment arm (randomized subjects)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control arm (randomized subjects)
Number of subjects: 132
Study: 32379675

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Empathy Training (MBET)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 123
Study: 34627753

Group type: EXPERIMENTAL
Intervention: Video-Assisted Advance Care Planning (ACP) intervention
Number of subjects: 923

Group type: COMPARATOR
Intervention: Usual ACP practices (Control)
Number of subjects: 923
Study: 33639839

Group type: EXPERIMENTAL
Intervention: Sugammadex 2 mg/kg ABW
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Sugammadex 2 mg/kg IBW
Number of subjects: 188

Group type: COMPARATOR
Intervention: Neostigmine 5 mg and glycopyrrolate 1 mg
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Sugammadex 4 mg/kg ABW
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Sugammadex 4 mg/kg IBW
Number of subjects: 188
Study: 32678005

Group type: EXPERIMENTAL
Intervention: Advance care planning (ACP) intervention led by trained nurse facilitators, consisting of an information brochure and two ACP conversations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Educational program for nurses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semi-structured interviews with caregivers
Number of subjects: 0
Study: 35565656

Group type: EXPERIMENTAL
Intervention: Starch- and sucrose-reduced diet (SSRD)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Ordinary diet (Control)
Number of subjects: 105
Study: 33774169

Group type: EXPERIMENTAL
Intervention: 1000 mg of acetaminophen orally every 6 hours for 1 day prior to and after surgery, then every 8 hours during postoperative days 2-5, with the option to take 5 mg of oxycodone every 6 hours as needed after surgery.
Number of subjects: 57

Group type: COMPARATOR
Intervention: 5 mg of oxycodone every 6 hours as needed and 1000 mg of acetaminophen orally every 6 hours as needed after surgery.
Number of subjects: 57

Group type: COMPARATOR
Intervention: 5 mg of oxycodone every 6 hours as needed without any additional acetaminophen after surgery.
Number of subjects: 57
Study: 35358740

Group type: EXPERIMENTAL
Intervention: Dilapan‐S
Number of subjects: 674

Group type: COMPARATOR
Intervention: dinoprostone
Number of subjects: 674
Study: 34645165

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HIPEC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS)
Number of subjects: 0
Study: 32791583

Group type: EXPERIMENTAL
Intervention: Adenoidectomy plus myringotomy (group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adenoidectomy plus tympanostomy tube insertion (group B)
Number of subjects: 0
Study: 34797431

Group type: EXPERIMENTAL
Intervention: Tapered implant (TI)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Straight implant (SI)
Number of subjects: 20
Study: 33712246

Group type: EXPERIMENTAL
Intervention: Neck Collars (NC+)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Standard imaging (NC-)
Number of subjects: 125
Study: 34051345

Group type: EXPERIMENTAL
Intervention: 6% HP + LED/laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: 35% HP
Number of subjects: 20
Study: 35975308

Group type: EXPERIMENTAL
Intervention: GlyNAC supplementation for 16 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (isonitrogenous alanine) for 16 weeks
Number of subjects: 24
Study: 34976328

Group type: EXPERIMENTAL
Intervention: Remifentanil anesthesia
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sufentanil anesthesia
Number of subjects: 120
Study: 32741354

Group type: EXPERIMENTAL
Intervention: Weekly iron and folate supplement for adolescent girls
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Deworming programme twice per year
Number of subjects: 405
Study: 35394898

Group type: EXPERIMENTAL
Intervention: Inactivated Polio Vaccine (IPV)
Number of subjects: 1146
Study: 33832092

Group type: EXPERIMENTAL
Intervention: 1000 pulses of rTMS
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 2000 pulses of rTMS
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 4000 pulses of rTMS
Number of subjects: 29
Study: 35325467

Group type: EXPERIMENTAL
Intervention: High-dose glucocorticoid (10 mg/kg methylprednisolone)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Low-dose glucocorticoid (8 mg dexamethasone)
Number of subjects: 53
Study: 32882163

Group type: EXPERIMENTAL
Intervention: Prasugrel 5 mg after 1 month of 10 mg prasugrel plus 100 mg aspirin daily (de-escalation group)
Number of subjects: 2338

Group type: COMPARATOR
Intervention: Prasugrel 10 mg plus 100 mg aspirin daily (conventional group)
Number of subjects: 2338

Group type: EXPERIMENTAL
Intervention: Prasugrel-based de-escalation therapy
Number of subjects: 2338
Study: 33887247

Group type: EXPERIMENTAL
Intervention: Adjunctive host-directed therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 36206786

Group type: EXPERIMENTAL
Intervention: Peroral endoscopic myotomy
Number of subjects: 133

Group type: COMPARATOR
Intervention: Pneumatic dilation
Number of subjects: 133
Study: 32914830

Group type: EXPERIMENTAL
Intervention: SNS genetic risk‐by‐neighborhood social life interaction
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: SNS genetic risk‐by‐informal social control interaction
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: SNS genetic risk‐by‐neighborhood satisfaction interaction
Number of subjects: 228
Study: 32249441

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Blood clot (BLC)
Number of subjects: 26
Study: 34641873

Group type: EXPERIMENTAL
Intervention: cfDNA methylation classifier
Number of subjects: 401
Study: 32535263

Group type: EXPERIMENTAL
Intervention: Edaravone (0.5 mg/kg intravenous after induction of anesthesia)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 0
Study: 33547665

Group type: EXPERIMENTAL
Intervention: PBMT + SRP
Number of subjects: 60

Group type: COMPARATOR
Intervention: SRP
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 32448374

Group type: EXPERIMENTAL
Intervention: ADvisor internet programmes plus three patient telephone calls from a psychological wellbeing practitioner
Number of subjects: 402

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 402
Study: 35790326

Group type: EXPERIMENTAL
Intervention: Supported home exercise programme
Number of subjects: 210

Group type: COMPARATOR
Intervention: Face-to-face physiotherapy
Number of subjects: 210
Study: 34028550

Group type: EXPERIMENTAL
Intervention: Gamification with support
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Gamification with competition
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Gamification with collaboration
Number of subjects: 361

Group type: COMPARATOR
Intervention: Control
Number of subjects: 361
Study: 32350145

Group type: EXPERIMENTAL
Intervention: DS + SS
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: DS + FR
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: DS + VFR
Number of subjects: 23
Study: 35617211

Group type: EXPERIMENTAL
Intervention: Subtenon triamcinolone acetonide (TAAC) injection (4mg) with MMC‐TRAB
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard MMC‐TRAB
Number of subjects: 75
Study: 34914215

Group type: EXPERIMENTAL
Intervention: Single-suture knot
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Double-suture knot
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional circumcision without suture knot
Number of subjects: 120
Study: 34331235

Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 1000
Study: 33065642

Group type: EXPERIMENTAL
Intervention: Restrictive strategy
Number of subjects: 1067

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1067
Study: 34489744

Group type: EXPERIMENTAL
Intervention: Bergen 4-day treatment (B4DT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Self-help (SH)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Waitlist (WL)
Number of subjects: 48
Study: 32552721

Group type: EXPERIMENTAL
Intervention: General practitioner (GP) coordination of healthcare
Number of subjects: 811

Group type: COMPARATOR
Intervention: Sex (male vs. female)
Number of subjects: 811

Group type: COMPARATOR
Intervention: Morbidity
Number of subjects: 811

Group type: COMPARATOR
Intervention: Education (high vs. low)
Number of subjects: 811

Group type: COMPARATOR
Intervention: Household net adjusted disposable income
Number of subjects: 811

Group type: COMPARATOR
Intervention: Regional category (urban areas)
Number of subjects: 811

Group type: COMPARATOR
Intervention: Regional category (environs)
Number of subjects: 811

Group type: COMPARATOR
Intervention: Healthcare utilisation (each GP contact)
Number of subjects: 811

Group type: COMPARATOR
Intervention: Healthcare utilisation (each contact to a medical specialist)
Number of subjects: 811
Study: 36458119

Group type: EXPERIMENTAL
Intervention: Treatment as usual + aerobic exercise training (40-min twice a week for 8 weeks)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) only
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Treatment as usual + aerobic exercise training
Number of subjects: 94
Study: 32576199

Group type: EXPERIMENTAL
Intervention: ENG-releasing subdermal contraceptive implant
Number of subjects: 100

Group type: COMPARATOR
Intervention: Other contraceptive methods
Number of subjects: 100
Study: 35202795

Group type: EXPERIMENTAL
Intervention: Active-tDCS targeting primary motor cortex and dorsolateral prefrontal cortex
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham-tDCS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Active-tDCS
Number of subjects: 40
Study: 33461986

Group type: EXPERIMENTAL
Intervention: Electronic health record alerts for acute kidney injury
Number of subjects: 6030

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6030
Study: 34952813

Group type: EXPERIMENTAL
Intervention: Dense regimen of five sessions/week for 3 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-dense regimen of three sessions/week for 5 weeks (Control)
Number of subjects: 0
Study: 32451288

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) plus pharmacotherapy on demand
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard pharmacotherapy
Number of subjects: 86
Study: 35197493

Group type: EXPERIMENTAL
Intervention: Teleguided multidisciplinary intervention
Number of subjects: 58

Group type: COMPARATOR
Intervention: Usual care plus access to an educational website
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 33319739

Group type: EXPERIMENTAL
Intervention: PXVX0200 (1 × 10^9 CFU)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: PXVX0200
Number of subjects: 172
Study: 35857659

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy
Number of subjects: 847

Group type: COMPARATOR
Intervention: Placebo plus chemotherapy
Number of subjects: 847
Study: 32502772

Group type: EXPERIMENTAL
Intervention: Copper-oxide impregnated wound dressing (study group)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Non-copper wound dressing (control group)
Number of subjects: 324